Avid Bioservices CDMO
$ 12.3
-0.28%
Quarterly report 2024-Q3
added 12-10-2024
Avid Bioservices Balance Sheet 2011-2024 | CDMO
Annual Balance Sheet Avid Bioservices
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
17.5 M | -35.6 M | -121 M | -71.6 M | -9.41 M | -32.3 M | -42.3 M | -46.8 M | -61.4 M | -68 M | -77.5 M | -35.2 M | -18 M | -21.8 M |
Long Term Debt |
54.2 M | 1.56 M | 1.83 M | 96.9 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.35 M | 1.36 M | 3.11 M | 1.36 M | 1.23 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 21.2 M | 2.16 M | 2.16 M | 1.6 M | 1.4 M | 1.1 M | 639 K | 737 K | 1.14 M | 1.67 M |
Total Current Liabilities |
70.6 M | 215 M | 223 M | 70.9 M | 44.5 M | 23.2 M | 37.9 M | 62.9 M | 57.6 M | 37.3 M | 22.2 M | 20.6 M | 17.6 M | - |
Total Liabilities |
276 M | 262 M | 261 M | 188 M | 65.7 M | 25.3 M | 40 M | 64.5 M | 59 M | 38.4 M | 22.8 M | 21.3 M | 18.8 M | 19.3 M |
Deferred Revenue |
39.9 M | 37.4 M | 48.4 M | 50.8 M | 29.1 M | 14.7 M | 27.9 M | 45.5 M | 34.2 M | 18 M | 11 M | 12.2 M | 8.52 M | 7.38 M |
Retained Earnings |
-572 M | -431 M | -431 M | -560 M | -571 M | -561 M | -559 M | -537 M | -509 M | -454 M | -403 M | -368 M | -338 M | -296 M |
Total Assets |
337 M | 452 M | 443 M | 266 M | 108 M | 78.4 M | 95.8 M | 118 M | 109 M | 97.5 M | 90.5 M | 45.1 M | 28.3 M | 34.8 M |
Cash and Cash Equivalents |
38.1 M | 38.5 M | 126 M | 170 M | 36.3 M | 32.4 M | 42.3 M | 46.8 M | 61.4 M | 68 M | 77.5 M | 35.2 M | 18 M | 23.1 M |
Book Value |
60.9 M | 189 M | 182 M | 77.7 M | 41.9 M | 53.1 M | 55.7 M | 53.6 M | 50.1 M | 59 M | 67.7 M | 23.8 M | 9.48 M | 15.4 M |
Total Shareholders Equity |
60.9 M | 189 M | 175 M | 77.7 M | 41.9 M | 53.1 M | 55.7 M | 53.6 M | 50.1 M | 59 M | 67.7 M | 23.8 M | 9.48 M | 15.4 M |
All numbers in USD currency
Quarterly Balance Sheet Avid Bioservices
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
52.9 M | 53.6 M | 7.1 M | 54.9 M | 55.5 M | 48.6 M | 1.56 M | 44 M | 41.8 M | 42.7 M | 2.09 M | 20.2 M | 43.8 M | - | - | 21.6 M | 20.6 M | 20.9 M | - | - | 22.4 M | 23.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
279 M | 276 M | 276 M | 275 M | 271 M | 252 M | 262 M | 258 M | 261 M | 272 M | 255 M | 82.8 M | 251 M | 188 M | 188 M | 58.1 M | 64.2 M | 59 M | 65.7 M | - | 25.3 M | - | 25.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
51.7 M | 37.7 M | 39.9 M | 52.9 M | 46.4 M | 33 M | 37.4 M | 59 M | 48.4 M | 52.8 M | 53.8 M | 47.7 M | 51.9 M | 46.3 M | 50.8 M | 26.4 M | 31.4 M | 27.1 M | 29.1 M | 14.6 M | 22.2 M | 18.1 M | 14.7 M | 6.63 M | 17.3 M | 18 M | 10.9 M | 26.4 M | 7.47 M | 13.4 M | 28.5 M | 15.4 M | 18 M | 21.5 M | 10 M | 5.75 M | 9.69 M | 8.29 M | 6.63 M | 4.33 M | 3.61 M | 4.67 M | 5.24 M | 5.06 M | 3.47 M | 4.16 M | 4.17 M | 2.55 M | 6.22 M | 6.06 M | 3.65 M | - | 2.01 M | 4.14 M | 5.62 M |
Retained Earnings |
-595 M | -577 M | -572 M | -449 M | -442 M | -433 M | -431 M | -547 M | -431 M | -430 M | -431 M | -562 M | -549 M | -553 M | -560 M | -566 M | -564 M | -566 M | -571 M | -561 M | -564 M | -564 M | -561 M | -562 M | -560 M | -558 M | -556 M | -532 M | -551 M | -539 M | -537 M | -497 M | -524 M | -520 M | -509 M | -441 M | -481 M | -467 M | -454 M | -393 M | -428 M | -416 M | -403 M | -359 M | -383 M | -376 M | -368 M | -327 M | -355 M | -346 M | -338 M | - | -316 M | -304 M | -296 M |
Total Assets |
323 M | 335 M | 337 M | 455 M | 455 M | 442 M | 452 M | 314 M | 442 M | 451 M | 430 M | 168 M | 302 M | 271 M | 266 M | 105 M | 114 M | 106 M | 108 M | 76.1 M | 105 M | 102 M | 78.4 M | 69.9 M | 80.2 M | 84.7 M | 95.8 M | 111 M | 78.6 M | 100 M | 118 M | 119 M | 110 M | 106 M | 109 M | 79.1 M | 113 M | 92 M | 97.5 M | 76.5 M | 81.4 M | 87.6 M | 90.5 M | 37.2 M | 55.1 M | 53.3 M | 45.1 M | 29.4 M | 36.5 M | 31.5 M | 28.3 M | - | 27.3 M | 27 M | 34.8 M |
Cash and Cash Equivalents |
33.4 M | 33.4 M | 38.1 M | 30.7 M | 31.4 M | 25.2 M | 38.5 M | 59.9 M | 77.3 M | 115 M | 126 M | 70.9 M | 164 M | 160 M | 170 M | 30.7 M | 35.7 M | 35.7 M | 28.2 M | 27.8 M | 34 M | 34 M | 28.9 M | 17.9 M | 32.7 M | 32.7 M | 37.5 M | 41.5 M | 27.7 M | 27.7 M | 37.3 M | 67.5 M | 49.1 M | 49.1 M | 44.2 M | 55.2 M | 72 M | 72 M | 59 M | 63.2 M | 64.4 M | 64.4 M | 73.3 M | 26.3 M | 44.4 M | 44.4 M | 41.6 M | 19.8 M | 24.4 M | 24.4 M | 19 M | 24.1 M | 18.1 M | 18.1 M | 16.5 M |
Book Value |
44.8 M | 58.6 M | 60.9 M | 180 M | 184 M | 191 M | 189 M | 56.6 M | 181 M | 179 M | 175 M | 85.4 M | 51.1 M | 82.8 M | 77.7 M | 47.1 M | 49.4 M | 46.5 M | 41.9 M | 76.1 M | 79.9 M | 102 M | 53.1 M | 69.9 M | 80.2 M | 84.7 M | 95.8 M | 111 M | 78.6 M | 100 M | 118 M | 119 M | 110 M | 106 M | 109 M | 79.1 M | 113 M | 92 M | 97.5 M | 76.5 M | 81.4 M | 87.6 M | 90.5 M | 37.2 M | 55.1 M | 53.3 M | 45.1 M | 29.4 M | 36.5 M | 31.5 M | 28.3 M | - | 27.3 M | 27 M | 34.8 M |
Total Shareholders Equity |
44.8 M | 58.6 M | 60.9 M | 180 M | 183 M | 190 M | 189 M | 185 M | 181 M | 179 M | 175 M | 85.4 M | 51.1 M | 44.6 M | 77.7 M | 47.1 M | 49.4 M | 49.4 M | 46.5 M | 53.1 M | 49.2 M | 49.2 M | 49.7 M | 31.5 M | 54.8 M | 54.8 M | 56.7 M | 40 M | 42.9 M | 56 M | 53.6 M | 59.9 M | 42.2 M | 40.9 M | 50.1 M | 49.8 M | 69.2 M | 55.4 M | 59 M | 55.1 M | 58.8 M | 65.6 M | 67.7 M | 17.4 M | 35.6 M | 32.5 M | 23.8 M | 12.9 M | 12.7 M | 3.92 M | 9.48 M | - | 12.5 M | 11.8 M | 15.4 M |
All numbers in USD currency